Beacon Capital Management LLC Purchases Shares of 480 Celsius Holdings, Inc. (NASDAQ:CELH)

Beacon Capital Management LLC purchased a new stake in Celsius Holdings, Inc. (NASDAQ:CELH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 480 shares of the company’s stock, valued at approximately $40,000.

Several other large investors have also made changes to their positions in CELH. Vanguard Group Inc. raised its stake in Celsius by 183.6% in the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock valued at $749,458,000 after purchasing an additional 8,899,873 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Celsius by 212.2% during the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock worth $185,018,000 after purchasing an additional 2,306,598 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Celsius by 424.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock worth $152,287,000 after purchasing an additional 2,261,046 shares during the period. Eagle Asset Management Inc. grew its holdings in shares of Celsius by 188.8% during the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after purchasing an additional 1,934,400 shares during the period. Finally, Artisan Partners Limited Partnership purchased a new position in shares of Celsius during the 4th quarter worth $101,116,000. 60.95% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Hal Kravitz sold 16,500 shares of Celsius stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total transaction of $1,489,455.00. Following the completion of the transaction, the director now directly owns 201,282 shares of the company’s stock, valued at $18,169,726.14. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, major shareholder William H. Milmoe sold 428,574 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $59.67, for a total value of $25,573,010.58. Following the completion of the transaction, the insider now directly owns 23,964,450 shares of the company’s stock, valued at $1,429,958,731.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Hal Kravitz sold 16,500 shares of the business’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total value of $1,489,455.00. Following the completion of the transaction, the director now directly owns 201,282 shares of the company’s stock, valued at $18,169,726.14. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 915,481 shares of company stock valued at $56,491,739. 2.20% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. B. Riley decreased their target price on Celsius from $110.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday, July 22nd. Truist Financial started coverage on Celsius in a research report on Tuesday, June 25th. They issued a “hold” rating and a $60.00 price target on the stock. BNP Paribas started coverage on Celsius in a research report on Monday, June 24th. They set an “outperform” rating and a $87.00 target price on the stock. Bank of America cut their target price on Celsius from $84.00 to $60.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Finally, Jefferies Financial Group cut their target price on Celsius from $98.00 to $68.00 and set a “buy” rating on the stock in a research report on Monday, July 22nd. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Celsius currently has an average rating of “Moderate Buy” and a consensus price target of $76.51.

Celsius Stock Down 4.3 %

Shares of Celsius stock traded down $2.02 during trading on Thursday, reaching $44.81. The company’s stock had a trading volume of 4,603,851 shares, compared to its average volume of 5,095,702. Celsius Holdings, Inc. has a 12-month low of $44.04 and a 12-month high of $99.62. The company has a market capitalization of $10.44 billion, a P/E ratio of 51.14, a price-to-earnings-growth ratio of 1.43 and a beta of 1.90. The business has a 50 day moving average price of $61.78 and a 200-day moving average price of $69.88.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.07. Celsius had a return on equity of 111.29% and a net margin of 18.63%. The firm had revenue of $355.70 million for the quarter, compared to the consensus estimate of $390.37 million. During the same period in the previous year, the business earned $0.13 earnings per share. The company’s revenue for the quarter was up 36.9% compared to the same quarter last year. Research analysts predict that Celsius Holdings, Inc. will post 1.05 EPS for the current fiscal year.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.